Schaper Benz & Wise Investment Counsel Inc Abb Vie Inc. Transaction History

Schaper Benz & Wise Investment Counsel Inc

  • $1.21 Billion
  • Q3 2024

A detailed history of Schaper Benz & Wise Investment Counsel Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Schaper Benz & Wise Investment Counsel Inc holds 5,615 shares of ABBV stock, worth $984,758. This represents 0.09% of its overall portfolio holdings.

Number of Shares
5,615
Previous 5,615 -0.0%
Holding current value
$984,758
Previous $963,000 15.06%
% of portfolio
0.09%
Previous 0.09%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024
SELL
$154.79 - $180.76 $17,800 - $20,787
-115 Reduced 2.01%
5,615 $963,000
Q1 2024

Apr 29, 2024
BUY
$159.82 - $182.1 $3,995 - $4,552
25 Added 0.44%
5,730 $1.04 Million
Q3 2023

Oct 11, 2023
SELL
$133.59 - $154.65 $6,679 - $7,732
-50 Reduced 0.87%
5,705 $850,000
Q1 2023

May 01, 2023
SELL
$144.61 - $166.54 $35,429 - $40,802
-245 Reduced 4.08%
5,755 $917,000
Q4 2022

Jan 25, 2023
SELL
$138.31 - $165.87 $49,100 - $58,883
-355 Reduced 5.59%
6,000 $0
Q2 2022

Aug 04, 2022
BUY
$137.62 - $174.96 $85,186 - $108,300
619 Added 10.79%
6,355 $973,000
Q1 2022

Apr 29, 2022
BUY
$131.98 - $163.75 $197,969 - $245,625
1,500 Added 35.41%
5,736 $930,000
Q2 2021

Jul 29, 2021
BUY
$105.21 - $117.21 $34,193 - $38,093
325 Added 8.31%
4,236 $477,000
Q4 2020

Feb 11, 2021
BUY
$80.49 - $108.67 $21,893 - $29,558
272 Added 7.47%
3,911 $419,000
Q3 2020

Nov 05, 2020
SELL
$85.91 - $100.83 $60,137 - $70,581
-700 Reduced 16.13%
3,639 $319,000
Q2 2020

Jul 30, 2020
BUY
$73.37 - $98.18 $586 - $785
8 Added 0.18%
4,339 $426,000
Q1 2020

May 04, 2020
SELL
$64.5 - $97.79 $129,000 - $195,580
-2,000 Reduced 31.59%
4,331 $330,000
Q3 2019

Nov 04, 2019
SELL
$62.98 - $75.72 $45,660 - $54,897
-725 Reduced 10.27%
6,331 $479,000
Q2 2019

Aug 05, 2019
SELL
$65.7 - $83.98 $111,690 - $142,766
-1,700 Reduced 19.42%
7,056 $513,000
Q1 2019

Apr 23, 2019
SELL
$77.14 - $90.79 $202,492 - $238,323
-2,625 Reduced 23.06%
8,756 $706,000
Q3 2018

Oct 19, 2018
SELL
$88.91 - $98.84 $393,782 - $437,762
-4,429 Reduced 28.01%
11,381 $1.08 Million
Q1 2018

Apr 30, 2018
SELL
$92.01 - $123.21 $73,608 - $98,568
-800 Reduced 4.82%
15,810 $1.5 Million
Q4 2017

Jan 26, 2018
SELL
$89.56 - $98.21 $15,673 - $17,186
-175 Reduced 1.04%
16,610 $1.61 Million
Q3 2017

Nov 02, 2017
BUY
$69.85 - $89.22 $27,939 - $35,688
400 Added 2.44%
16,785 $1.49 Million
Q2 2017

Aug 07, 2017
BUY
N/A
16,385
16,385 $1.19 Million

Others Institutions Holding ABBV

# of Institutions
3,852
Shares Held
1.25B
Call Options Held
16.8M
Put Options Held
12.2M
View Full List

About AbbVie Inc.

ABBV Quotes by TradingView
  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Schaper Benz & Wise Investment Counsel Inc Portfolio

Follow Schaper Benz & Wise Investment Counsel Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schaper Benz & Wise Investment Counsel Inc, based on Form 13F filings with the SEC.

News

Stay updated on Schaper Benz & Wise Investment Counsel Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email